vs

Side-by-side financial comparison of MDU RESOURCES GROUP INC (MDU) and Revvity (RVTY). Click either name above to swap in a different company.

Revvity is the larger business by last-quarter revenue ($772.1M vs $522.6M, roughly 1.5× MDU RESOURCES GROUP INC). MDU RESOURCES GROUP INC runs the higher net margin — 14.6% vs 12.7%, a 1.9% gap on every dollar of revenue. On growth, Revvity posted the faster year-over-year revenue change (5.9% vs -1.6%). Revvity produced more free cash flow last quarter ($161.8M vs $-336.0M). Over the past eight quarters, Revvity's revenue compounded faster (9.0% CAGR vs -5.7%).

MDU Resources Group, Inc. is a U.S.-based corporation supplying products and services to regulated energy delivery and utilities related construction materials and services businesses. It is headquartered in Bismarck, North Dakota, and operates in 48 states.

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.

MDU vs RVTY — Head-to-Head

Bigger by revenue
RVTY
RVTY
1.5× larger
RVTY
$772.1M
$522.6M
MDU
Growing faster (revenue YoY)
RVTY
RVTY
+7.4% gap
RVTY
5.9%
-1.6%
MDU
Higher net margin
MDU
MDU
1.9% more per $
MDU
14.6%
12.7%
RVTY
More free cash flow
RVTY
RVTY
$497.8M more FCF
RVTY
$161.8M
$-336.0M
MDU
Faster 2-yr revenue CAGR
RVTY
RVTY
Annualised
RVTY
9.0%
-5.7%
MDU

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDU
MDU
RVTY
RVTY
Revenue
$522.6M
$772.1M
Net Profit
$76.3M
$98.4M
Gross Margin
Operating Margin
20.5%
14.5%
Net Margin
14.6%
12.7%
Revenue YoY
-1.6%
5.9%
Net Profit YoY
38.4%
3.9%
EPS (diluted)
$0.37
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDU
MDU
RVTY
RVTY
Q4 25
$522.6M
$772.1M
Q3 25
$313.6M
$698.9M
Q2 25
$348.7M
$720.3M
Q1 25
$678.0M
$664.8M
Q4 24
$531.0M
$729.4M
Q3 24
$290.7M
$684.0M
Q2 24
$343.1M
$691.7M
Q1 24
$588.2M
$649.9M
Net Profit
MDU
MDU
RVTY
RVTY
Q4 25
$76.3M
$98.4M
Q3 25
$18.3M
$46.7M
Q2 25
$13.8M
$53.9M
Q1 25
$82.0M
$42.2M
Q4 24
$55.2M
$94.6M
Q3 24
$64.6M
$94.4M
Q2 24
$60.4M
$55.4M
Q1 24
$100.9M
$26.0M
Gross Margin
MDU
MDU
RVTY
RVTY
Q4 25
Q3 25
53.6%
Q2 25
54.5%
Q1 25
56.5%
Q4 24
Q3 24
56.3%
Q2 24
55.7%
Q1 24
54.6%
Operating Margin
MDU
MDU
RVTY
RVTY
Q4 25
20.5%
14.5%
Q3 25
12.7%
11.7%
Q2 25
8.7%
12.6%
Q1 25
16.6%
10.9%
Q4 24
17.8%
16.3%
Q3 24
12.0%
14.3%
Q2 24
11.5%
12.4%
Q1 24
16.4%
6.8%
Net Margin
MDU
MDU
RVTY
RVTY
Q4 25
14.6%
12.7%
Q3 25
5.8%
6.7%
Q2 25
4.0%
7.5%
Q1 25
12.1%
6.4%
Q4 24
10.4%
13.0%
Q3 24
22.2%
13.8%
Q2 24
17.6%
8.0%
Q1 24
17.2%
4.0%
EPS (diluted)
MDU
MDU
RVTY
RVTY
Q4 25
$0.37
$0.86
Q3 25
$0.09
$0.40
Q2 25
$0.07
$0.46
Q1 25
$0.40
$0.35
Q4 24
$0.26
$0.77
Q3 24
$0.32
$0.77
Q2 24
$0.30
$0.45
Q1 24
$0.49
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDU
MDU
RVTY
RVTY
Cash + ST InvestmentsLiquidity on hand
$28.2M
$919.9M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$2.8B
$7.3B
Total Assets
$7.6B
$12.2B
Debt / EquityLower = less leverage
0.97×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDU
MDU
RVTY
RVTY
Q4 25
$28.2M
$919.9M
Q3 25
$75.9M
$931.4M
Q2 25
$58.8M
$991.8M
Q1 25
$59.5M
$1.1B
Q4 24
$66.9M
$1.2B
Q3 24
$88.3M
$1.2B
Q2 24
$78.8M
$2.0B
Q1 24
$72.7M
$1.7B
Total Debt
MDU
MDU
RVTY
RVTY
Q4 25
$2.7B
Q3 25
$2.4B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.3B
Q1 24
$2.3B
Stockholders' Equity
MDU
MDU
RVTY
RVTY
Q4 25
$2.8B
$7.3B
Q3 25
$2.7B
$7.4B
Q2 25
$2.7B
$7.6B
Q1 25
$2.7B
$7.6B
Q4 24
$2.7B
$7.7B
Q3 24
$3.1B
$7.9B
Q2 24
$3.0B
$7.9B
Q1 24
$3.0B
$7.8B
Total Assets
MDU
MDU
RVTY
RVTY
Q4 25
$7.6B
$12.2B
Q3 25
$7.2B
$12.1B
Q2 25
$6.9B
$12.4B
Q1 25
$7.0B
$12.4B
Q4 24
$7.0B
$12.4B
Q3 24
$8.2B
$12.8B
Q2 24
$8.0B
$13.4B
Q1 24
$7.8B
$13.4B
Debt / Equity
MDU
MDU
RVTY
RVTY
Q4 25
0.97×
Q3 25
0.86×
Q2 25
0.80×
Q1 25
0.80×
Q4 24
0.85×
Q3 24
0.76×
Q2 24
0.75×
Q1 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDU
MDU
RVTY
RVTY
Operating Cash FlowLast quarter
$80.6M
$182.0M
Free Cash FlowOCF − Capex
$-336.0M
$161.8M
FCF MarginFCF / Revenue
-64.3%
21.0%
Capex IntensityCapex / Revenue
79.7%
2.6%
Cash ConversionOCF / Net Profit
1.06×
1.85×
TTM Free Cash FlowTrailing 4 quarters
$-297.0M
$509.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDU
MDU
RVTY
RVTY
Q4 25
$80.6M
$182.0M
Q3 25
$57.9M
$138.5M
Q2 25
$117.4M
$134.3M
Q1 25
$217.5M
$128.2M
Q4 24
$60.5M
$174.2M
Q3 24
$140.2M
$147.9M
Q2 24
$136.5M
$158.6M
Q1 24
$165.1M
$147.6M
Free Cash Flow
MDU
MDU
RVTY
RVTY
Q4 25
$-336.0M
$161.8M
Q3 25
$-121.9M
$120.0M
Q2 25
$36.5M
$115.5M
Q1 25
$124.4M
$112.2M
Q4 24
$-95.8M
$149.8M
Q3 24
$673.0K
$125.6M
Q2 24
$26.5M
$136.6M
Q1 24
$48.1M
$129.7M
FCF Margin
MDU
MDU
RVTY
RVTY
Q4 25
-64.3%
21.0%
Q3 25
-38.9%
17.2%
Q2 25
10.5%
16.0%
Q1 25
18.4%
16.9%
Q4 24
-18.0%
20.5%
Q3 24
0.2%
18.4%
Q2 24
7.7%
19.7%
Q1 24
8.2%
20.0%
Capex Intensity
MDU
MDU
RVTY
RVTY
Q4 25
79.7%
2.6%
Q3 25
57.3%
2.6%
Q2 25
23.2%
2.6%
Q1 25
13.7%
2.4%
Q4 24
29.4%
3.4%
Q3 24
48.0%
3.3%
Q2 24
32.0%
3.2%
Q1 24
19.9%
2.7%
Cash Conversion
MDU
MDU
RVTY
RVTY
Q4 25
1.06×
1.85×
Q3 25
3.16×
2.97×
Q2 25
8.52×
2.49×
Q1 25
2.65×
3.03×
Q4 24
1.10×
1.84×
Q3 24
2.17×
1.57×
Q2 24
2.26×
2.87×
Q1 24
1.64×
5.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDU
MDU

Natural Gas Distribution$382.8M73%
Commercial Utility Sales$42.7M8%
Residential Utility Sales$33.7M6%
Pipelineand Midstream$31.1M6%
Natural Gas Transportation$17.2M3%
Industrial Utility Sales$10.1M2%
Natural Gas Storage$6.4M1%
Other Utility Sales$1.9M0%

RVTY
RVTY

Immunodiagnostics$240.8M31%
Life Sciences$191.4M25%
Reproductive Health$149.3M19%
Segment Operating Income$132.0M17%
Software$62.3M8%

Related Comparisons